“Rising Preference for Aesthetic Dermatology and Non-Invasive Treatment Modalities”
- A significant and accelerating trend in the seborrheic keratosis treatment market is the growing demand for aesthetic dermatological procedures that are minimally invasive, quick, and deliver superior cosmetic outcomes. Patients—especially older adults and professionals—are increasingly seeking removal of benign lesions from visible areas such as the face, neck, and hands for aesthetic purposes.
- For instance, Alma Lasers (Israel) launched the Harmony XL Pro, an advanced multi-technology platform that includes laser-based treatments for benign pigmented lesions like SK. The device is widely used in dermatology clinics across Europe and Asia for fast and scar-minimized removal.
- Similarly, Cutera (U.S.) has expanded the use of its excel V+ laser platform, which is FDA-cleared for treating superficial skin irregularities, including seborrheic keratosis. Dermatologists have reported improved patient outcomes, particularly in patients seeking cosmetic enhancements.
- The market is also witnessing a rise in portable, in-clinic devices that support walk-in procedures, allowing patients to receive treatment without prolonged downtime. Devices like CryoPen X+ are becoming popular among clinics for precise, non-contact cryotherapy for SK lesions.
- Additionally, Aclaris Therapeutics (U.S.) has been developing topical pharmacologic treatments under its AKARI Therapeutics pipeline, aimed at non-invasive, at-home management of non-malignant skin lesions, indicating a shift toward convenience-driven care models.
